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ABSTRACT
Objectives: Intraoperative radiotherapy (IORT) relates to irradiation of diseased tissue during the surgery within the tumor 
bed. The reason for this process is based on the fact that the increase in the radiation dose increases local tumor control. 
It was shown that postoperative fluids obtained from patients after breast cancer conserving surgery, stimulated motility 
and invasiveness of tumor cells in vitro. The results obtained from TARGIT clinical trial demonstrated that IORT significantly 
inhibits the stimulatory effect of wound fluids on tumor cells in vitro. We therefore speculated that wound fluids collected 
from patients after IORT treatment may induce the apoptosis in breast cancer cell lines and it may be a reason for their 
lower proliferation rate and potential to metastasis. 
Material and methods: Breast cancer MCF7 cell line was incubated with wound fluids collected from patients after conserv-
ing breast cancer surgery or surgery followed by IORT for 4 days. Then the expression of markers associated with extrinsic 
or intrinsic apoptosis pathway was established. 
Results: Our results clearly indicate activation of extrinsic apoptosis pathway by wound fluids collected from patients after 
IORT treatment. No changes in apoptotic markers were seen in cells treated with wound fluids collected from patients 
after the surgery alone. 
Conclusions: Thus we confirmed that wound fluids collected from patients after IORT treatment may induce the apoptosis 
in breast cancer cell lines and it may be a reason for their lower proliferation rate and invasiveness of tumor cells in vitro.
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INTRODUCTION
The development of normal tissue depends on the ba-
lance between cell proliferation and apoptosis. It is believed 
that the growth of the tumor is not only caused by uncon-
trollable proliferation of cells but also by reduced apoptosis 
rate. It is speculated that low levels of apoptosis are charac-
teristic for a poor prognosis in breast cancer. Nevertheless 
many research show that programmed cell death is often 
increased in malignant tumors, however it is then often 
followed by high levels of proliferation [1]. Increased resi-
stance of human breast cancer cells to apoptosis is induced 
by high expression of IL-6 and IL-6R. Moreover, as shown by 
Wang et al. IL-17 can suppress apoptosis and promote tumor 
proliferation, survival and metastasis by upregulating the 
expression of VEGF, MMP2 and MMP9 [2]. It has been proven 
that surgery and especially wound fluids secreted from 
tissue after the surgery induces inflammatory response [3]. 
Moreover until recently a hypothesis has been made, that 
external inflammatory pathways promote or even initiate 
cancer [4]. Many studies revealed that approximately 90% of 
local recurrences in the breast after surgery appears in the 
same quadrant as the primary cancer [5]. The published data 
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suggest that this process of recurrence is caused by wound 
healing process which alters the tumor microenvironment 
thus leading the tumor to be more favorable to recur [3]. 
Intraoperative radiotherapy (IORT) relates to irradiation of 
diseased tissue during the surgery within the tumor bed [6]. 
The reason for this process is based on the evidence that the 
increase in the radiation dose increases local tumor control. 
Studies of Belletti and Tagliabule [7, 8] have shown that po-
stoperative fluids obtained from patients after breast cancer 
conserving surgery stimulated motility and invasiveness of 
tumor cells in vitro. The results obtained from TARGIT clinical 
trial demonstrated that IORT significantly inhibits the stimu-
latory effect of WF on tumor cells in vitro [7]. This effect may 
be due to both direct cell killing by ionizing radiation and by 
the modulation of tumor microenvironment [9]. It was proved 
that during the procedure of IORT, the cells produce specific 
cytokines and chemokines that affect non-irradiated cells [10]. 
Those molecules produced in the response to irradiation may 
fulfill both pro- and anti-apoptotic functions in cancer. Thus 
we speculated, that wound fluids after IORT may induce the 
apoptosis in breast cancer cells and it may be a reason for 
a lower proliferation and capability to metastasis. 
Apoptosis is a conserved program of controlled cell 
death, that is seen in various physiological and pathological 
situations [11]. It is believed that cancer cells are able to 
evade apoptosis and thus mostly the anticancer therapies 
results in the activation of apoptosis pathway mainly by 
activation of caspases [12]. Activation of caspases activity 
is initiated both at the plasma membrane level by death 
receptors (receptor = extrinsic pathway) and at a mitochon-
drial level (mitochondrial = intrinsic pathway) [11]. While 
the activation of extrinsic apoptosis pathway is dependent 
on stimulation of death receptors by external stimuli, the 
activation of intrinsic pathway is a result of intracellular 
stimuli like for example DNA damage [13].
Objectives
The aim of this research is to analyze the effect of post-
-surgical wound fluids after IORT treatment on the expres-
sion of the markers associated with apoptosis. We believe 
the findings reported here will contribute to better under-
standing of biological processes involved in response of 
breast cancer cells to IORT treatment and will be particularly 
relevant in the effectiveness of breast cancer treatment.
MATERIAL AND METHODS
Surgical wound fluids
Wound fluids were collected from patients 7 days after 
breast cancer surgery by percutaneous aspiration. They were 
divided into two groups. One group consisted of patients, 
which underwent breast cancer conserving surgery (quadra-
nectomy) (WF group; age at diagnosis = 50 ± 11.4, ER status: 
100% ER positive, HER status: 0% HER2 positvie, histopatho-
logical status: 100% ductal). The second group consisted of 
patients, in whom the surgery was followed by intraoperative 
radiation therapy given as a boost of 10 Gy (RT-WF group; age 
at diagnosis = 55.8 ± 10,03, ER status: 100% ER positive, HER 
status: 0% HER2 positvie; histopathological status: 100% duc-
tal). Wound fluids were collected as described elsewhere [14]. 
Shortly fluids were collected by percutaneous aspiration, cen-
trifuged for 25 min at 300 × g at 4°C, sterile filtered and stored 
at –80°C. This study was approved by the Bioethics Committee 
of Poznan University of Medical Sciences number 756/16.
Cell culture 
A luminal subtype of breast cancer cell line 
— MCF7 (Er/PgR+; HER2/Neu-) was obtained from the 
American Type Culture Collection (ATCC, Rockville, MD) and 
cultured according to ATCC instructions in a humidified 
atmosphere with 5% carbon dioxide and 37° C (BINDER, 
Germany). Cells were incubated with 10% of WF or RT-WF in 
Dulbecco’s Modified Eagle’s Medium (DMEM, BIOWEST, UT) 
with 10% fetal bovine serum (FBS, BIOWEST, UT) for 4 days 
and then subjected to RNA isolation. Control cells were 
cultured in standard medium (10% FBS in DMEM) under 
the same conditions. This cell line was chosen based on 
ER/PR.HER2 status of patients from each wound fluids were 
collected. Based on the receptor expression, MCF7 cell line 
corresponds the best with patient’s cancer status.
RNA isolation and RT-PCR
Total RNA was isolated using TRI Reagent (Sigma-Aldrich, 
MI), according to the manufacturer’s instructions. The RNA 
was eluted in DEPC-treated H2O and stored at –80°C until 
further analyses. 1 µg of RNA was then subjected to reverse 
transcription using iSCRIPT kit (BioRad, CA) according to 
manufacturer’s instructions.
Real-time quantitative PCR (RT-qPCR)
The expression of markers associated with intrinsic and 
extrinsic apoptosis pathway was analyzed using RealTime UPL 
Probes Master system (Roche, Basel, Switzerland) on LightCyc-
ler96 (Roche, Basel, Switzerland). The expression of analyzed 
genes was normalized to the expression of beta actin reference 
gene. The fold-differences in genes expression were calcula-
ted using the comparative Cq (ΔΔCq) method. Quantitative 
differential expression was calculated as 2-ΔΔCq [15].
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
(GraphPad Software, CA). Data were examined using the 
One-Way ANOVA with Tukey post hoc test and differences 
were considered significant at p < 0.05. Data are displayed 
as mean ± SD.
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RESULTS
Effects of WF and RT-WF on the induction of 
apoptosis pathway 
To study a potential effect of surgical wound fluids after 
intraoperative radiotherapy on the induction of extrinsic 
and intrinsic apoptosis pathway, human breast cancer cells 
(MCF7 cell line) were incubated for 4 days either with WF or 
RT-WF. Then the expression level of genes associated with 
extrinsic and intrinsic apoptosis pathway was assessed by 
RT-qPCR.
Extrinsic apoptosis pathway
The extrinsic apoptosis pathway is associated with the 
activation of CASP8 or CASP10 by binding of a ligand to cell 
surface receptors. The expression of genes involved in extrin-
sic apoptosis pathway was assessed by RT-qPCR in MCF7 cell 
line stimulated with WF or RT-WF. The untreated cells were 
used as a control. A highly significant increase in the expres-
sion of TNF (tumor necrosis factor) and TRAIL (TNF-related 
apoptosis-inducing factor) was observed after stimulation 
with RT-WF (TNF = 3.51 ± 0.02, TRAIL = 8.15 ± 2.08) while 
comparing to untreated cells (CTR) (TNF = 0.78 ± 0.3, TRA-
IL = 0.918 ± 0.117). No statistically significant changes in the 
expression of those markers were seen in WF stimulated gro-
up (TNF = 0.38 ± 0.03, TRAIL = 2.96 ± 0.61). The TNF receptor 
family has more than 20 receptors. They activate apoptosis 
by a cytoplasmic domains that recruit the death domain 
containing adaptor FAS-associated via death domain (FADD) 
protein. Then FADD recruits CASP8 and/or 10 which in turn 
results in the activation of apoptosis pathway [16]. Therefore, 
the expression of two death receptors as well as FASS and 
CASP8 and CASP10 was analyzed. An increase in the expres-
sion of two TNF receptors: TNFRSF10A (DR4) and TNFRSF10B 
(DR5) was observed in RT-WF treated MCF7 cells (TNFRS-
F10A = 1.47 ± 0.16, TNFRSF10B = 1.92 ± 0.13) comparing to 
CTR (TNFRSF10A = 1.01 ± 0.0001, TNFRSF10B = 1.13 ± 0.18). 
No significant changes in WF treated group were observed 
(TNFRSF10A = 1.01 ± 0.0001, TNFRSF10B = 1.38 ± 0.04). On 
the contrary to previously mentioned markers of extrinsic 
pathway of apoptosis, FADD expression was statistically de-
creased in WF treated cells (0.853 ± 0.008) comparing to CTR 
(1 ± 0.00001). While a significant increase was observed for 
CASP10 expression in RT-WF group (5.38 ± 0.009) compared 
to both CTR (1.19 ± 0.27) and WF (2.11 ± 0.80), no significant 
change in CASP8 activity was observed. (CTR = 0.984 ± 0.065, 
WF = 0.958 ± 0.14, RT-WF = 1.2 ± 0.24) (Fig. 1).
Intrinsic apoptosis pathway
The expression of 7 genes involved in extrinsic apoptosis 
pathway was assessed by RT-qPCR in MCF7 cell line stimu-
lated with WF or RT-WF. The untreated cells were used as 
a control. In the intrinsic (mitochondrial) apoptosis pathway, 
the activation of caspase activity is related to permeabiliza-
tion of the outer mitochondrial membrane by the Bcl family 
members. In the MCF7 cell line treated with WF and RT-WF 
a significant decrease in Bcl-2 expression was observed in 
WF treated cells (0.201 ± 0.007) comparing both to CTR 
(0.993 ± 0.01) and RT-WF group (0.863 ± 0.095). Upon di-
sruption of the outer mitochondrial membrane, cytochrome 
c is released which results in the formation of cytochrome 
c/APAF-1/CASP9 apoptosome complex which in turn trig-
gers CASP3, CASP6 and CASP9 activation. While in analyzed 
MCF7 cell line no change in APAF-1 expression was observed 
in any of analyzed groups (CTR = 1.04 ± 0.06, WF = 1.1 ± 0.15, 
RT-WF = 1.17 ± 0.34), the CASP9 was slightly increased in 
both WF (1.33 ± 0,1) and RT-WF treated cells (1.18 ± 0.04) 
compared to CTR (0.99 ± 0.01). From the other caspase 
family members, only decrease in CASP3 activity was ob-
served in WF treated cells (0.648 ± 0.07) compared both to 
CTR (1.0 ± 0.0001) and RT-WF treated cells (0.818 ± 0.177). 
DIABLO expression also did not change after any of wound 
fluids stimuli (CTR = 0.954 ± 0.065, WF = 0.967 ± 0.057, RT-
-WF = 0.996 ± 0.211) (Fig. 2).
DISCUSSION
The wound healing process after breast cancer conse-
rving surgery activates inflammatory responses, which are 
known to modify tumor microenvironment and growth 
kinetics of breast cancer metastasis [3, 17]. Those results 
suggest, that wound fluids can be a significant factor in 
a local recurrence or development of metastasis. As proved 
by Belletti et al. [7] cytokines and growth factors present in 
the wound fluids are involved in the stimulation of mam-
mary carcinoma cells. Their work confirms that wound fluids 
harvested from breast cancer patients, who underwent 
conserving breast cancer surgery, triggers the motility of 
breast cancer cells, their invasion and growth in three-di-
mensional culture. Authors also prove, that this effect may 
be partially abrogated by wound fluids collected from pa-
tients after IORT treatment. The inhibitory effect of wound 
fluids collected from breast cancer patients after IORT on the 
proliferation was also confirmed by Veldwijk et al. [18]. These 
findings are consistent with the published data, showing 
that IORT treatment changes the tumor microenvironment 
by modulating the concentration of cytokines in wound 
fluids. IL-6 is one of the cytokines whose concentration 
is significantly decreased in wound fluids collected from 
patients after IORT [7]. Upon binding to its membrane re-
ceptor, it activates JAK/STAT3 signaling pathway. Consistent 
with these findings, Segatto et al. confirmed that STAT3 was 
highly activated in breast cancer cells following stimulation 
with wound fluids [19]. While IL-6 activity is much decreased 
in IORT treated patients, thus they assumed and confirmed 
afterwards, that breast cancer cells treated with wound 
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fluids collected from IORT patients show lower proliferation 
rate, than cells incubated with wound fluids after the surgery 
only. They also showed, that the suppression of STAT3 activi-
ty in breast cancer cells significantly decreased the growth of 
tumor in STAT3-silenced mouse model. STAT3 activity is sti-
mulated by IL-6. All of these factors can affect proliferation of 
the breast cancer cells, however questions have been raised 
concerning the activation of death pathway in RT-WF treated 
cells. Based on these results, we postulated that decreased 
proliferation capability of breast cancer cell lines stimulated 
with RT-WF may be caused by activation of apoptotic pa-
thway in those cells. Thus we incubated MCF7 cell line with 
WF and RT-WF and analyzed the transcriptomic activation 
of apoptosis. We analyzed both the markers of extrinsic 
and intrinsic apoptosis pathway. The findings presented 
in this study indicate, that extrinsic pathway of apoptosis 
is activated in response to RT-WF stimulation of MCF7 cell 
line. The expression of genes involved in the different sta-
ges of apoptosis pathway were highly enriched in RT-WF 
group compared to CTR and WF stimulated cells. Likewise, 
we did not observe any changes in the expression of genes 
involved in intrinsic apoptosis pathways after RT-WF stimu-
lation comparing to untreated cells. An opposite results are 
observed in WF stimulated MCF7 cell line. The expression of 
both extrinsic and intrinsic apoptosis markers was not chan-
ged or slightly decreased in response to WF. These findings 
provide valuable data on the activation of apoptosis path-
way by external stimuli in RT-WF group. Moreover, they are 
supported by the fact previously described by Belletti et al. 
[7], that IORT changes the proteomic profile of wound fluids, 
which results in different biological activities of RT-WF and 
WF observed in proliferation and motility assays. Based on 
our data, we can speculate, that wound fluids collected from 
the patients after IORT treatment affect the proliferation of 
Figure 1. Effects of WF and RT-WF on the induction of extrinsic apoptosis 
pathway. Breast cancer MCF7 cell line was incubated with 10% of wound 
fluids collected 7 days after the surgery (WF) or after a surgery followed by 
IORT treatment (RT-WF). After 4 days the expression of markers associated 
with extrinsic apoptosis pathway was evaluated. Graphs represent relative 
mRNA fold change normalized to untreated control MCF7 cells. Samples 
were assessed in triplicate and analyzed using One-Way ANOVA with Tukey 
post hoc test and differences were considered significant at p < 0.05
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MCF7 cell line by inducing apoptosis in those cells. Higher 
proliferation and motility of breast cancer cells after WF 
stimulation may be due to lack of apoptosis induction, thus 
leading to higher proliferation rate.
It has been proven that killing of the cancer cells in 
cancer therapy has been associated with the activation of 
apoptosis pathway [20]. A critical component in apoptotic 
cell death plays activation of proteolytic enzymes known as 
caspases. Many signaling pathways activated in anticancer 
therapies result in activation of caspases. Depending on 
the type of apoptotic pathway, different caspases are being 
activated. The extrinsic apoptosis pathway results mainly 
in activating CASP8 or/and CASP10, while intrinsic apop-
tosis pathway results in activation of CASP3/6/9. While the 
caspases are key components of apoptotic pathway, many 
anticancer therapies focus on targeting upstream molecules 
of apoptotic pathway. Many studies investigated a potential 
role of TRAIL in combination with chemotherapeutic drugs 
in order to intensify cell death and/or overcome resistance 
to common treatment [21, 22]. Concomitant administration 
of TRAIL and the chemotherapeutic drugs caused significant 
activation of caspases [21]. TRAIL is an inducer of extrinsic 
apoptosis pathway that acts through a complicated receptor 
system. Based on the selectivity of the soluble recombinant 
TRAIL towards transformed cells, this molecule is a promi-
sing therapeutic agent in cancer. As mentioned by Wang et 
al. identifying new agents that target death receptors may 
be useful for cancer therapy [23]. Experiments on breast 
cancer cell lines suggested that they are very resistant to 
TRAIL-induced apoptosis. In addition in many of them this 
effect may be overcome by concomitant administration 
of chemo- or radiotherapy [24]. According to Ashkenazi 
et al. administration of recombinant soluble TRAIL in mo-
use model significantly induces tumor regression without 
Figure 2. Effects of WF and RT-WF on the induction of intrinsic apoptosis 
pathway. Breast cancer MCF7 cell line was incubated with 10% of wound 
fluids collected 7 days after the surgery (WF) or after a surgery followed by 
IORT treatment (RT-WF). After 4 days the expression of markers associated 
with intrinsic apoptosis pathway was evaluated. Graphs represent relative 
mRNA fold change normalized to untreated control MCF7 cells. Samples 
were assessed in triplicate and analyzed using One-Way ANOVA with Tukey 
post hoc test and differences were considered significant at p < 0.05
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systemic toxicity [25]. Moreover, it is important to point out 
that TRAIL induces apoptosis regardless of p53 status and 
thus has a high ability to kill cancer cells with the mutation 
in the p53 gene [26]. As shown by Chinnaiyan et al. radiation 
intensifies TRAIL-mediated apoptosis in both cell lines and 
tumor xenografts [27]. There is evidence that ER expressing 
cell lines are resistant to the induction of apoptosis by TRAIL 
alone [21, 22, 28]. Those authors found out that synergistic 
interaction between TRAIL and chemotherapeutic drugs 
can overcome TRAIL resistance in ER positive breast cancer 
cells. A study by Lagadec et al. [29] showed that tamoxifen 
can intensify TRAIL-induced apoptosis in breast cancer cells 
both in vitro and in vivo. Based on our data we believe that 
IORT treatment can overcome the TRAIL-dependent resi-
stance to apoptosis. Nevertheless, given the preliminary 
nature of the current study, more research is needed to 
reach definitive conclusions. 
The induction od DR5 expression is very important in 
TRAIL induced apoptosis [26]. Thus targeting this receptor 
may be a promising factor in cancer therapy. Wang et al. 
also pointed out that upregulation of DR5 in tumors that 
retain some responsiveness to therapy might lead to the 
activation of apoptosis and reduce the probability of tumor 
cells to be resistant to treatment [26]. We confirmed that 
DR5 expression is significantly induced in RT-WF treated 
cells. While the patients after IORT treatment may also get 
concomitant radiotherapy after the surgery, based on our 
results we can assume, that activation of apoptosis may 
sensitize them for further radiation treatment comparing 
to patients which underwent surgery alone. However this 
conclusion is not without risk, given that apoptosis is a very 
complex process and more research is needed to reach 
definitive conclusions.
Another important aspect in cancer therapy is induction 
of TRAIL-dependent apoptosis together with histone deace-
tylase (HDAC) inhibitors. Many cancers display increased 
expression of HDAC, which thus results in condensation of 
chromatin and downregulation of genes associated with 
tumor suppression. The HDAC inhibitors used as anticancer 
therapy show promising effects in both pre-clinical and 
clinical setting [30] by inducing cell cycle arrest, promoting 
differentiation, and causing cancer death [31]. Moreover 
HDAC inhibitors are shown to be an efficient radiosensiti-
zers in many cancer cell lines [32−34]. In several preclinical 
studies it has been shown that combining HDAC inhibitors 
with TRAIL induces the apoptosis in breast cancer cells, 
however the exact mechanism of this induction is still not 
known [35, 36]. It has been proposed, that the enhancement 
of this process may be due to upregulation of TRAIL recep-
tors, redistribution of TRAIL receptors, down-regulation of 
antiapoptotic proteins, and up-regulation of proapoptotic 
proteins such as Bcl-2 [37]. Given the elevated expression 
of TRAIL-related apoptosis markers our results together 
with the findings presented by Chopin et al. and Singh at al. 
[35, 36] may indicate, that concomitant treatment of IORT 
and HDAC inhibitors is likely to be a benefit in outcome on 
breast cancer patients. 
CONCLUSIONS
In this paper we have described the activation of two 
apoptotic pathways: extrinsic and intrinsic, on the transcript 
level upon incubation of breast cancer MCF7 cell line with 
wound fluids collected from patients after breast cancer 
conserving surgery or breast cancer conserving surgery 
followed by IORT treatment. Our finding provides a valuable 
data on the activation of extrinsic apoptotic pathway in 
MCF7 cell line after incubation with wound fluids collected 
from patients after IORT. We believe that our findings will 
contribute to better understanding of biological processes 
involved in response of breast cancer cells to IORT treatment 
and will be particularly relevant in the effectiveness of breast 
cancer treatment.
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